Purchase Order HHSD2002017M95531P

Award Date 9/1/17
Potential Completion Date 2/28/19
Potential Value $150K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $85,272.00, was issued by the Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract is for research services related to "TRUE DIABETES INCIDENCE AND DETECTION IN THE U.S. ADULT PUPLATION." This appears to be a prime contract with no set-aside designation. The services provided include compartment modeling, risk score analysis, and projections on the...
The Department of Health and Human Services, Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to the German non-profit organization Deutsche Diabetes Forschungsgesellschaft E.V. for a $146,715.00 diabetes research project. The contract, which had no set-aside designation, funds mathematical modeling and analysis services to forecast diabetes prevalence and assess the impact of risk factors, including the effect of the COVID-19 pandemic. This award is part of...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the impact of changes in diabetes risk score components on future diabetes prevalence. The $178,519.19 contract, awarded on August 6, 2021, does not have a set-aside designation and is scheduled to conclude on August 31,...
This $180,000.00 firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services, to Joslin Diabetes Center, Inc., a non-profit organization based in Boston, Massachusetts. The contract does not have a set-aside designation. The purpose of this award is to provide specialized research-related services and materials to support NIDDK's diabetes studies. Joslin...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract, valued at $196,324.31, is for the application of compartment models to forecast diabetes prevalence and assess the impact of various risk factors, including the effect of the COVID-19 pandemic. The contract has a period of performance ending on...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the prevalence of late diabetes in Pima Indians in the United States. The contract is a firm fixed-price purchase order with a potential value of $147,876.39 and a completion date of September 29, 2018. Deutsche Diabetes...
This federal contract award to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, provides $199,339.00 in funding for a project to model the future number of people with diabetes in the United States and assess the impact of the COVID-19 pandemic. The work is being performed for the U.S. Centers for Disease Control and Prevention (CDC) and includes compartment modeling, risk score analysis, and projections. This is a Firm Fixed Price purchase order contract with...
This is a $799,770.00 firm-fixed-price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to ABT Associates Inc., a global consulting and research firm, to develop and evaluate innovative methods, tools, and strategies to increase employer adoption. The contract is not set-aside. ABT Associates frequently serves as a prime contractor on federal awards, leveraging its expertise across various domains such as public health, education, and...
This federal contract award is for a study titled "TAS::75 0843::TAS ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES", with a total ceiling value of $877,743.52. The prime contractor is Wake Forest University Health Sciences (WFUHS), a leading academic medical center that frequently partners with the federal government on biomedical research, medical training, and clinical services contracts and grants. The contract has no set-aside designation and was awarded by the National...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $249,973.00 firm fixed price purchase order contract to the Research Triangle Institute (RTI International), a nonprofit research organization, to develop a "State Diabetes Health Burden Toolkit". The contract has a completion date of June 30, 2024 and was awarded on August 15, 2022. No set-aside designation was used for this contract. RTI International has a history of supporting various federal agencies through...

This $149,893.46 firm fixed-price purchase order contract was awarded by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention to the Baker Heart and Diabetes Institute, a non-profit research organization, to conduct research on trends in the incidence of young onset Type 2 diabetes. The contract, which did not have a set-aside designation, was completed in February 2019. In addition to this prime contract, Baker Institute has also frequently served as a subcontractor on federal grants awarded to other institutions, providing specialized lipid profiling and bioinformatics capabilities to support research on diseases such as Alzheimer's, coronary artery disease, and diabetes.

Generated 3/23/24, 11:52 AM